PhiC31 integrase as a promising tool in nonviral gene therapy di Raphael Liesner edito da Südwestdeutscher Verlag für Hochschulschriften AG  Co. KG
Alta reperibilità

PhiC31 integrase as a promising tool in nonviral gene therapy

EAN:

9783838123509

ISBN:

3838123506

Pagine:
144
Formato:
Paperback
Lingua:
Tedesco
Acquistabile con o la

Descrizione PhiC31 integrase as a promising tool in nonviral gene therapy

Phage-derived FC31 integrase represents an attractive tool for site-directed recombination in mammalian cells. Integration is based on recombination between attachment site attB and wt/pseudo-attP` site. Disadvantages are inefficient nonviral gene delivery and aberrant events (15% chromosomal rearrangements/deletions) within the host genome. The study's aim was to increase safety and efficiency of FC31 integrase. DNA binding domain was mutated by alanine scan, 22 mutants were evaluated for improved integration and intramolecular recombination. The combination of beneficial mutations in addition to optimization of the integrase plasmid dose enhanced integration efficiencies from 1.7 to 5.5-fold. Several mutants showed cell line-dependent integration activities. Excision assays between native attB/attP sites revealed 5 mutants with 2-fold enhanced activity. Enhanced recombination between attB and 3 described attP' sites (hot spots) in the mammalian genome assumed preferred specificity. 2 mutants showed similar integration activity as wt due to hFIX expression in mouse hepatocytes. Mutational analysis revealed an efficient approach for improvements of integration efficiency in vitro.

Spedizione gratuita
€ 72.20
o 3 rate da € 24.07 senza interessi con
Disponibile in 10-12 giorni
servizio Prenota Ritiri su libro PhiC31 integrase as a promising tool in nonviral gene therapy
Prenota e ritira
Scegli il punto di consegna e ritira quando vuoi

Recensioni degli utenti

e condividi la tua opinione con gli altri utenti